Seeking Alpha

Shares of European drug giant Sanofi (SNY -4%) slide today, despite announcing that the European...

Shares of European drug giant Sanofi (SNY -4%) slide today, despite announcing that the European Commission has granted marketing authorization in Europe for its diabetes treatment Lyxumia. The drug is indicated for the treatment of adults with type 2 diabetes mellitus, and helps achieve glycemic control.
Comments (2)
  • chopchop0
    , contributor
    Comments (3420) | Send Message
     
    Considering how much it has run up in recent weeks, it was probably due for a pullback like this
    4 Feb 2013, 02:42 PM Reply Like
  • biochemist
    , contributor
    Comments (354) | Send Message
     
    All European stocks are getting hammered today.
    4 Feb 2013, 06:37 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector